Smaller cos. enter space
A number of smaller manufacturers of male contraceptives are launching into the market to challenge the big three: Church & Dwight (72.8% dollar share in the category), Ansell Healthcare (11.6% dollar share) and Reckitt Benckiser (11.5% dollar share).
It’s one factor expected to drive more marketing around the category. Sales of condoms for the 52 weeks ended June 10 reached $295.5 million, up 5.1%, across food, drug and mass (excluding Walmart), according to SymphonyIRI Group.
The fact that there are condoms that are not Trojan, LifeStyles and Durex, respectively, that are hitting the market may not be entirely new. But relative newcomer NüVo Condoms has gained distribution through Walgreens — and affiliates Duane Reade and USA Drug — according to its website, while Billy Boy reported distribution gains across two national retailers coming out of NACDS Marketplace.
Global Protection and its One Condoms have been on the market for a while and can be found at select Walgreens, CVS/pharmacy stores in California, and Kerr Drug, according to the company’s website. Global Protection also manufactures store-brand contraceptives, and sales of private-label condoms are up 1,825% for the 52 weeks ended June 10, according to SymphonyIRI Group. Also making headway into the device end of the business is RH Labs. In July the company introduced a line of personal massagers endorsed by sex and relationship expert Laura Berman.
The article above is part of the DSN Category Review Series. For the complete Intimacy Health Buy-In Report, including extensive charts, data and more analysis, click here.
ST. PAUL, Minn. — UltiMed’s UltiCare Micro 4mm x 32G pen needle is its shortest, thinnest pen needle, according to the company, which also said the needle provides a more comfortable injection for patients living with diabetes. The Micro offers all the comfort features of the leading pen needle at a lower cost to pharmacists and a less painful injection experience to the patient. It is compatible with all pens sold in the United States and is available in an easy to dispense 50-count box or 100-count UltiGuard Safe Pack that combines pen needles and an approved sharps container all in one system.
ReportersNotebook — Chain Pharmacy, 8/6/12
SUPPLIER NEWS — The Food and Drug Administration has approved Watson Pharmaceuticals’ Next Choice One Dose (levonorgestrel) tablets in the 1.5-mg strength. The drug is an emergency contraceptive used to prevent pregnancy following unprotected sex or contraceptive failure. It is a generic version of Teva Women’s Health’s Plan B One-Step, which had sales of about $88 million during the 12-month period ended in March, according to IMS Health.
The FDA has approved Lupin Pharmaceuticals’ pregabalin capsules in the 25-mg, 50-mg, 75-mg, 100-mg, 150-mg, 200-mg, 225-mg and 300-mg strengths. The drug is used to treat fibromyalgia, partial-onset seizures in adults, neuropathic pain associated with diabetic peripheral neuropathy and post-herpetic neuralgia. It is a generic version of C.P. Pharmaceuticals’ Lyrica, which had sales of about $1.8 billion during the 12-month period that ended in March, according to IMS Health.
The FDA has given priority review status to applications for Xarelto (rivaroxaban) as a treatment for deep-vein thrombosis — a condition in which clots form in one of the large deep veins, usually in the legs — and pulmonary embolism, which occurs when a DVT clot dislodges and is carried to the lung via the heart, Johnson & Johnson subsidiary Janssen Research & Development said.